Zofran Lawsuit Alleges Drug Caused Infant Boy’s Fatal Birth Defects

November 15, 2015 – – ZofranLegal.com reports on another lawsuit filed against Zofran by a grieving mother in Kentucky. The suit alleges that the defects her infant son was born with, which proved fatal, were caused by exposure to the anti-nausea drug while he developed in utero. Her suit was filed in the United States District Court for the Eastern District of Kentucky against pharmaceutical conglomerate GlaxoSmithKline.

The suit is not uncommon in its allegations. Across the United States, many other similar suits have been filed alleging a variety of birth defects caused by the anti-nausea medication. Most commonly, the suits discuss cleft lip and palate and congenital heart defects, such as atrial septal defects and ventricular septal defects.

In this particular case, the mother explains that she was prescribed Zofran to treat nausea associated with morning sickness during her first trimester. She insists in details that no one ever mentioned the potential of birth defects to her before recommending the drug, which was never approved or tested for safety on pregnant women.

Zofran was approved by the U.S. Food and Drug Administration to treat nausea for individuals who have undergone chemotherapy, radiation, or anesthesia. Despite this, however, manufacturer GlaxoSmithKline allegedly marketed the drug “off-label” to Ob/Gyns across the nation, who then prescribed the medication “off-label” to pregnant mothers.

On April 7th of 2012, the plaintiff in this case gave birth to her son, and an immediate medical evaluation showed that he suffered from several congenital heart defects. One of these defects was hypoplastic right heart syndrome. Only 8 days after being born, the infant boy died from heart failure due to the defects. The family had no prior history of heart defects.

Unfortunately, there are many others who find themselves in the same situation as this mother. The attorneys at Monheit Law are currently working to ensure that anyone who has been in this situation or who has given birth to a child with defects after using Zofran is able to fully explore their legal rights. These individuals and their children may be entitled to compensation. Michael Monheit of Monheit law is offering free consultations to them at this time.

For more information regarding Zofran birth defects, or to ask questions, please contact Michael Monheit, Esq. by calling 877-620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60005370